PreserVision AREDS Formula + Multivitamin Launched for AMD Patients

The updated formula is based on results from the AREDS2 study, started in 2006
The updated formula is based on results from the AREDS2 study, started in 2006

Valeant announced that its subsidiary Bausch + Lomb has launched PreserVision AREDS 2 Formula + Multivitamin for patients with moderate to advanced age-related macular degeneration

The new 2-in-1 product is the first to combine the recommended AREDS 2 nutrient formula with other essential vitamins and minerals found in daily multivitamins. The formula contains the exact levels of all six clinically proven nutrients recommended by the National Eye Institute to decrease the risk of progression in patients with moderate to advanced age-related macular degeneration. 

Related Articles

PreserVision AREDS 2 Formula + Multivitamin is beta carotene-free and contains high Vitamin D to support the needs of older adults. The formula adds on the original PreserVision AREDS formula, with lutein and zeaxanthin replacing beta-carotene based on the recent AREDS2 Study. The study was initiated in 2006 to see if the original AREDS formulation could be improved. Researchers tried adding omega-3 fatty acids as well as lutein and zeaxanthin, which belong to the same family of nutrients as beta-carotene. The data indicated that while omega-3 fatty acids had no effect on the formulation, lutein and zeaxanthin together appeared to be a safe and effective option to beta-carotene.

PreserVision AREDS 2 Formula + Multivitamin is available in cartons of 120 softgels. 

For more information call (800) 553-5340 or visit PreserVision.com.

Loading links....